Retatrutide dosing Retatrutide has been studied at doses ranging from 0.5 mg to 12 mg in clinical trials
Of those people, some experienced side effects not observed in clinical trials, specifically body temperature and hormonal/menstrual disruptions
What your provider needs to know When you discuss timing changes, bring your injection log
At lower doses, plan to discard remaining solution after the stability period
Preparation makes the difference between pushing through and giving up
From microneedles to nanocarriers, researchers are rethinking how GLP-1 medicines could become longer-lasting, easier to tolerate, and more patient-friendly, while cautioning that many next-generation systems remain years from routine clinical use